Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Upstream Bio (UPB) EBIT Margin: 2023-2025

Historic EBIT Margin for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to -5,539.39%.

  • Upstream Bio's EBIT Margin fell 242686.00% to -5,539.39% in Q3 2025 from the same period last year, while for Sep 2025 it was -5,020.08%, marking a year-over-year decrease of 203974.00%. This contributed to the annual value of -3,281.18% for FY2024, which is 159572.00% down from last year.
  • According to the latest figures from Q3 2025, Upstream Bio's EBIT Margin is -5,539.39%, which was down 17.04% from -4,732.87% recorded in Q2 2025.
  • Over the past 5 years, Upstream Bio's EBIT Margin peaked at -1,511.43% during Q3 2023, and registered a low of -5,656.01% during Q1 2025.
  • Moreover, its 3-year median value for EBIT Margin was -3,439.22% (2024), whereas its average is -3,757.22%.
  • Data for Upstream Bio's EBIT Margin shows a maximum YoY tumbled of 331,023bps (in 2025) over the last 5 years.
  • Over the past 3 years, Upstream Bio's EBIT Margin (Quarterly) stood at -3,184.44% in 2023, then tumbled by 110,887bps to -4,293.31% in 2024, then plummeted by 242,686bps to -5,539.39% in 2025.
  • Its EBIT Margin was -5,539.39% in Q3 2025, compared to -4,732.87% in Q2 2025 and -5,656.01% in Q1 2025.